Cardio Flashcards

1
Q

risk factors aortic dissection

A

FAT CASH

  • family hx
  • atherosclerosis
  • takayasu
  • connective tissue disease
  • smoking
  • HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

aortic dissection pathophys, path and classification

A

pathophys

  • risk factors weaken vessel wall
  • cystic medial degeneration
  • > loss of elastic fibres
  • > loss of extracellular matrix
  • > increase in GAGs
  • laplaces law
  • > wall tension proportionate to radius and pressure
  • > inversely proportional to wall thickness
  • > cycle of wall degeneration and increasing stress
  • intimal tear
  • > creation of false lumen within laminar plane of media
  • extension
  • > retrograde or anterograde
  • occlusion
  • > static with obliteration of branching vessel by haematoma on same side
  • > dynamic during diastole when true lumen collapses and intimal flap closes over ostium on opposite side

path

  • stanford classification
  • > A = involves ascending +/- descending and thoracic
  • > B = does not involve ascending (usually distal to left subclavian)
  • microscopic
  • > cystic medial degeneration
  • > haematoma within laminar planes of media
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

aortic dissection investigations

A

ECG

FBC
-anaemia with haemorrhage
EUCs
-ischaemia = elevated BUN
LFTs
-ischaemia = transaminitis
lactate 
-ischaemia
blood type and cross match
trops
d-dimer
-sensitive but non specific

CXR
-widened medistinum
CTA
-intimal flap

TOE
-if CTA unavailable or in ED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hx and exam AAA

A

hx:

  • ruptured triad
  • > back/abdo pain
  • > pulsatile mass
  • > hypotension
  • focused on assessing risk factors
  • development
  • > hyperlipidaemia
  • > connective tissue disease
  • > COPD
  • > hypertension
  • expansion
  • > cardiac or renal transplant
  • > severe cardiac disease
  • > stroke
  • > older age
  • rupture
  • > female sex
  • > previous cardiac or renal transplant
  • > hypertension
  • smoking
  • > risk factor for development/expansion/rupture
  • family hx

exam

  • pulsatile and expansile mass
  • peripheral pulses
  • > evidence of ischaemia or emboli?
  • additional aneurysms
  • eccymoses
  • > cullens
  • > grey turners
  • > fox’s (thigh)
  • > bryants (scrotum)
  • fevers
  • > suspicion for infective AAA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

investigations AAA

A

ABG
-acidosis

FBC
-anaemia
->haemorrhage
-leukocytosis 
->infective/inflammatory AAA
EUCs
-acidosis
-AKI
LFTS
-shock and end organ damage
Coags
Trops
D-dimer
-associated with aneursym diameter
ESR
-infective/inflammatory AAA

Ultrasound

  • high sensitivity and specificity
  • thresholds
  • > diameter 1.5x normal
  • > 3cm

Consider

  • MRA/CTA
  • > surgical planning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

AAA/dissection ddx

A

Pain (RAPID MEDS)

  • ruptured viscus
  • AAA
  • pancreatitis
  • infarct (MI)
  • dissection
  • mesenteric ischaemia
  • embolism
  • diverticulitis
  • stones

Mass for AAA

  • lymphoma
  • lymph nodes
  • > lymphadenopathy
  • > mets
  • abscess
  • hernia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

AAA treatment

A

ruptured

  • surgical repair
  • > endovascular (lower mortality than open)
  • > open
  • medical support
  • > ABCD
  • > blood products
  • > ICU

symptomatic
-requires surgery regardless of size

small asymptomatic

  • no improvement in mortality with immediate surgery
  • surveillance
  • > every 6-12 months
  • medical management
  • > cease smoking
  • > cardiovascular risk factor control

large asymptomatic

  • surgery indicated
  • > greater than 5.5cm in men
  • > greater than 5cm in women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

lipid targets

A

*every reduction reduces events

LDL

  • primary prevention = 2mmol/L
  • secondary = 1.8 mmol/L

HDL
-1mmol/L

non-HDL
-2.5mmol/L

Total cholesterol
-4mmol/L

Triglycerides
-2mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

investigations APO

A
ECG
-arrhythmias
ABG
-hypoxia
-acid/base
-electrolytes
PEFR
-ddx cardiac vs pulmonary
Ultrasound
-B lines
FBC
-anaemia
-leukocytosis
EUC
-eGFR
-electrolytes
CMP
-arrhythmia 
BNP/NT-BNP
-elevated in exacerbation CCF
-specific and sensitive
Troponins
-subendocardial ischaemia with LV pressure
TSH
D-dimer
-strong negative predictive value

CXR

  • cardiomegaly
  • butterfly
  • air bronchogram
  • effusion
  • ddx’s

Echo

  • LV size and wall thickness
  • LV function
  • estimate EF and pulmonary wedge pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ddx APO

A
Exacerbation of CCF (A Reduction In Cardiac Output)
arrhythmias
-AF
regurgitation 
-mitral (endocarditis, myxoma, papillary rupture)
-aortic (endocarditis, dissection)
infarct/ischaemia
crisis (hypertensive crisis)
overload (renal, drugs, fluids)

Dyspnoea (DICTAATE)

  • reconditioning
  • infection/inflammatory (pneumonia, bronchiectasis, bronchitis, ILD)
  • COPD/asthma
  • tumour (effusion)
  • anaemia
  • ascities
  • thyroid dysfunction
  • embolism (pulmonary)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

dukes modified criteria

A

Pathologic:

  • pathologic lesions (on histology)
  • > vegetation
  • > intracardiac abscess

Clinical:

  • Definite
  • > two major
  • > one major + three minor
  • > five minor
  • Rejected
  • > symptoms resolve <4 with antibiotics
  • > no histo in surgery or autopsy <4 of antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

major clinical dukes criteria

A
  • Positive culture
  • > typical organisms from 2 seperate blood cultures
  • > persistently positive blood culture
    1) 2 cultures taken >12 hrs apart for typical or
    2) 3/3 or 2-3/4 cultures for skin flora
    3) single positive culture for Coxiella or
    4) positive Q fever IgG antibody titre
  • Evidence of endocardial involvement
  • > positive echo
    1) oscillating intracardiac mass
    2) abscess
    3) new partial dehiscence of prosthetic valve
  • > new valvular regurg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

minor criteria dukes

A

1) predisposition
- typical heart condition
- IVD

2) fever

3) vascular phenomena
- major emboli
- septic pulmonary infarcts
- mycotic aneurysm
- intracranial haemorrhage
- conjunctival petechiae
- Janeway lesions

4) immunologic phenomena
- GNP
- oslers nodes
- roths spots
- rheumatoid factor

5) microbio evidence
- positive culture not meeting major criteria
- serologic evidence of typical organism infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IE ddx

A

PAALMER

  • PE (ddx’s: EMPPATHIC)
  • Atrial myxoma
  • Autoimmune/vasculitis (eg. rheumatoid or scleroderma)
  • Libmann saccs
  • > malignancy (lung, colon, pancreatic)
  • > SLE
  • > antiphospholipid
  • MI with mural thrombus
  • Emboli (cholesterol)
  • Rheumatic heart disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CXR findings IE

A
PE signs 
-hamptoms hump
-westermark sign
Septic emboli
-cavitating nodules
CCF
-cardiomegaly
-batwing/butterfly
-airbronchogram
-effusion
DDx's
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

investigations IE

A

ECG
-heart block
Urinalysis
-GNP

Blood cultures
-before antibiotics
-3 sets
-3 sites
-first and last >1hr apart
FBC
EUC
RF
Complement
ESR
Echo (TTE/TOE)
-oscillating mass
-abscess
-partial dehiscence of prosthetic valve
-new regurg
CXR
-septic emboli
-caviating infiltrate
-cardiomegaly
CT chest/abdo/pelvis
-systemic emboli
->infarct
->abscess

Consider
-MRI brain

17
Q

pathophys MI

A

Ischaemia effects (atherosclerosis)

  • metabolism of fatty acids reduced, anaerobic glycolysis increased
  • decreased production ATP
  • decreased pH with lactate formation
  • impaired K/Na pump and membrane integrity leads to increase in K efflux and Na/Ca influx
  • regional failure of normal relaxation (decreases blood flow further), failed contraction (decreased supply)
  • relatively poorer perfusion to subendocardium compared to subepicardium
  • <20 mins = reversible
  • > 20 mins = permanent necrosis
18
Q

distribution of STEMI

A
  • LAD = approx 40%
  • RCA = approx 1/3
  • circumflex = approx 1/4
19
Q

Heart rupture in MI

A

Left ventricular free wall

  • 1% of MI
  • most common anterior left ventricle
  • early (<72 hrs) and late (<2 weeks) presentation
  • fibrinolytic therapy can accelerate rupture
  • presents with haemopericardium and tamponade (Beck’s triad: hypotension, muffled heart sounds, elevated neck veins + electrical alternans) –> PEA
  • mortality rate = 25%

Interventricular septum

  • less common than free wall
  • major risk factor is wrap around LAD
  • hypotension, biventricular heart failure and harsh pan systolic murmur +/- thrill
  • 50%

Papillary rupture

  • LV
  • hypotension, pulmonary oedema, LV heave and pan systolic murmur
20
Q

short and long term complications MI

A

Short (BIRD)

  • bradycardia/block (1st and 2nd) in RCA and complete in LAD
  • infarct/ischaemia (recurrent)
  • rupture (free wall, ventricular septum, papillary muscle)
  • dresslers syndrome (pericarditis)

Long (PACT)

  • psychological (depression)
  • arrhythmias (VT, VF)
  • CCF
  • thrombosis (mural –> systemic embolism)
21
Q

management CCF and APO

A

CCF:

Non Pharm:
education
-condition
-drugs
daily weights
fluid restriction (1.5L)
salt restriction
exercise
heart failure program
-heart failure nurse
dietician 
-anorexia

Pharm:

  • ACEI and beta blockers
  • swap with ARBs or aldosterone antagonists
  • supplement with loops
  • monitor and maintain iron

APO:

  • furosemide IV
  • high flow oxygen or CPAP
  • add nitroglycerol
  • dobutamine
  • morphine
22
Q

Blood pressure ranges and targets

A

Range

  • normal = <120 SBP, <80DBP
  • prehypertension = 130-40 SBP, 80-90 DBP
  • HTN = >140 SBP, >90 DBP

Effects

  • linear increase in cardiovascular events
  • linear increase in mortality above SBP 115

Targets

  • general = <140/90
  • high CVD absolute risk + SBP > 130 = SBP <120
23
Q

non pharm treatment of HTN

A

Complement pharm, not replace

  • Exercise (aerobic)
  • weight loss
  • alcohol restriction
  • salt restriction
  • healthy diet
24
Q

pathology in HTN

A

Vessels

  • arterial stiffness is a cause and consequence of HTN
  • > ion transporter dysfunction (increased Na/H exchange)
  • > increased Na entry
  • > increased Na/Ca exchange ->increased contractility
  • > increased pH -> increased contractility for Ca concen
  • endothelial vasoactive dynsfuntion
  • > NO (dilate)
  • > endothelin (constrict)
  • enhanced atherosclerosis

Heart

  • most common cause of death in HTN
  • LV hypertrophy –> CCF (HFrEF/HFpEF) + arrhythmias + MI
  • CAD + microvascular disease -> MI

Brain

  • stroke
  • > HTN greatest risk factor (direct relation over age 65)
  • > vascular dementia
  • beta amyloid deposition
  • > cognitive impairment
  • > alzheimers
  • autoregulation = 50-150mmHg
  • > hypertensive encecphalopathy

Kidney

  • atherosclerosis of afferent arteriole
  • > ischaemia in glomerulus
  • > loss of autoregulation -> transmission of high pressure to glomerulus -> hyperfiltration and hypertrophy -> glomerulosclerosis
  • progresses to ischaemia of tubules and atrophy + focal necrosis of glomerular tuft
  • > proteinuria
25
Q

acute management STEMI

A

Determine pathway

  • confirm diagnosis (STEMI/NSTEMI)
  • risk stratify

General management

  • ACCU
  • 2x IV canula
  • O2
  • Cardiac monitoring + ECG
  • Routine bloods
  • CXR
  • nitroglycerine
  • beta blocker (atenolol/metoprolol)
  • morphine
STEMI
-dual antiplatelet (aspirin + P2Y12 inhibitor)
-LMWH or UFH
re-perfuse
-within 12 hours
-PCI reduces mortality/recurrence and stroke compared to fibrinolytic
PCI (balloon angioplasty/stenting)
-within 90 minutes
Fibrinolytic 
-alteplase or tenecteplase
-within 30 mins 
consider contraindications

NSTEMI

  • aspirin (without P2Y12 until after surgery)
  • LMWH or UFH
  • consider GpIIaIIIb inhibitor
  • high risk -> coronary angiography and revascularisation (stenting/bypass)
  • evidence supporting early intervention (eg. within 2 hours very high risk)
26
Q

Complications IE

A

CAMPER

Cardiac

  • CCF
  • perivalvular abscess
  • > heart block
  • intracardiac fistulae
  • pericarditis

Aneurysm
-mycotic aneurysms

MSK

  • septic arthritis
  • vertebral osteomyelitis

Pulmonary

  • infarct
  • abscess
  • effusion
  • pneumonia
  • pneumothorax

Embolic

  • brain
  • > haemorrhage/ischaemic stroke
  • > abscess
  • > meningitis
  • spleen
  • > infarct
  • > abscess
  • peripheries
  • > paralysis

Renal

  • infarct
  • abscess
  • glomerulonephritis
  • nephrotoxic drugs
  • AKI
27
Q

risk factors IE

A

CARDITIS

  • congenital heart disease (eg. bicuspid aortic valve)
  • age >60
  • recurrence
  • degenerative heart disease (rheumatic heart disease, prosthetic valve, mitral valve prolapse)
  • IV drug use
  • teeth (dental procedure, poor dentition)
  • IVC/implantable cardiac device
  • sex (male)
28
Q

IE pathophys

A

Undamaged endothelium is resistant to infection and thrombus formation

1) Direct infection by highly virulent organisms
- staph aureus
- fibronectin binding protein
- >adhesin: binding to fibronectin and fibrinogen
- >invasin: facilitates entry into endothelial cells
2) Endothelial injury due to high velocity blood jets or on the low pressure side of valve defect
- formation of platelet fibrin thrombus
- >acts as nidus
- >becomes colonised during transient bacteraemia

Growth of vegetation

  • proliferation of bacterium
  • > within cells
  • > within fibronectin matrix
  • release of tissue factor from endothelium and macrophages
  • > platelet deposition
  • > activation of extrinsic pathway

Layers of growth

  • organisms deep in vegetations are metabolically inactive
  • > resistance to antimicrobials
  • outer layer is proliferating and shed continuously
  • > emboli of vegetation fragments (local immune response)
  • > deposition of immune complexes
29
Q

hx and exam IE

A
Hx:
risk factors
fever/chills/malaise/night sweats
anorexia/weight loss
arthralgia/myalgia/back pain
abdo pain
chest pain/palpitations
dyspnoea/orthopnoea/PND
meningism/stroke/headache
haematuria/oliguria
Exam
petechiae (cutaneous/mucosal)
splinter haemorrhage
janeway
polyarthritis
osler
roth spots
dentition
focal neuro signs
murmur 
effusion/diminished breath sounds
splenomegaly 
vertebral pain
30
Q

Arrhythmia treatment

A

Regular and Narrow Tachy

  • ddx
  • > sinus tachy/SVT/atrial tachycardia/atrial flutter
  • sinus tachy
  • > treat underlying cause
  • SVT
  • > DC cardioversion if unstable
  • > consider vagal maneuvers then adenosine if stable
  • atrial tachycardia
  • > DC cardioversion if unstable
  • > if stable, beta blockers/non dihyrdropyridine CCB
  • atrial flutter
  • > treated liked AF

Irregular and Narrow Tachy

  • ddx
  • > AF/multifocal atrial tachy/atrial flutter variable conduction
  • AF
  • > unstable = DC cardioversion
  • > stable = beta blockers/non dihydropyridine CCB
  • > consider need for anticoagulation
  • multifocal atrial tachy/atrial flutter variable conduction
  • > usually underlying cardiac/pulmonary path
  • > usually stable
  • > treatment focused at addressing cause

Regular and Wide Tachy

  • ddx
  • > VT (until proven otherwise)
  • VT
  • > unstable = DC cardioversion
  • > stable = amiodarone or lidocaine

Irregular and Wide Tachy

  • ddx
  • > polymorphic VT/VF
  • polymorphic VT
  • > unconscious = DC cardioversion
  • > conscious with baseline long QT (torsades) = magnesium sulfate
  • > conscious with normal baseline QT (post MI) = cardioversion if unstable, beta blockers if stable
  • VF
  • > ALS

Bradycardia

  • only treat if shocked
  • atropine while preparing for temporary pacing
  • > atropine = 0.5mg
  • > pacing = transvenous or transcutaneous
  • consider dopamine or adrenaline if unsuccessful